Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02913417
Title Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors David Minor, MD

uveal melanoma


Ipilimumab + Nivolumab + Yttrium-90 microsphere therapy

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.